Bridge Biotherapeutics' Series B Round

Bridge Biotherapeutics raised a round of funding on September 28, 2017.

Bridge Biotherapeutics (브릿지바이오) is a virtually-operated clinical stage global biotech company, headquartered in Seongnam, Korea with its subsidiary at JLABS@TMC. The company is engaged in …

Articles about Bridge Biotherapeutics' Series B Round: